ERG and cancer: Nanoparticles containing docetaxel conjugated to miRNA2c, which is a direct target of ERG and a critical inhibitor of EMT and prostate cancer cell motility, have increased bioavailability and inhibited not only cancer cells but also cancer stem cells [117,118].